Preloader Close
  • Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
At a glance

TwistedNano

Project Focus

Chirality is the asymmetric property of an object that makes it distinguishable from its mirror image

Project Objectives

TwistedNano targets the EU priority area “Health and Safety” by developing a set of new-generation

Project Organization

The workplan structure is based on a strong collaboration between all partners

TwistedNano will be developed by a consortium of 6 European Academic Institutions (UnivAQ – Università degli Studi dell’Aquila, Italy,  MPL – Max Planck Institute for The Science of Light, Germany, EPFL – Ecole Polytechnique Fédérale de Lausanne, Switzerland, CNRS – Centre national de la recherche scientifique, France, IIT – Istituto Italiano di Tecnologia, Italy, and ICFO – The Institute of Photonic Sciences, Spain), a global industrial player in pharmaceutics (Dompé Farmaceutici S.p.A., Italy) and a young start-up(Foresee Biosystems, Italy).

 

TwistedNano aims at developing an innovative platform to measure tiny amounts of chiral drugs.

TwistedNano Intro (coming soon)

Publications

Recent scientific articles

Accessible Superchiral Near-Fields Driven by Tailored Electric and Magnetic Resonances in All-Dielectric Nanostructures

Ershad Mohammadi, Ahad Tavakoli, Parisa Dehkhoda, Yasaman Jahani, Kosmas L. Tsakmakidis, Andreas Tittl, and Hatice Altug
ACS Photonics, 2019 2019, 6, 8, 1939–1946

Independent phase modulation for quadruplex polarization channels enabled by chirality-assisted geometric-phase metasurfaces

Yueyi Yuan, Kuang Zhang, Badreddine Ratni, Qinghua Song, Xumin Ding, Qun Wu, Shah Nawaz Burokur & Patrice Genevet Duan Ling, et al. Nature Communications, 4186 (2020)

Project details

01/01/2019
48 months
€3.197.925
Andrea Marini (UNIVAQ)